Recommended Pages at investor.mylan.com

Mylan Inc. - Mylan Launches Generic Version of Caduet® Tablets

investor.mylan.com — “Mylan Inc. - Mylan Launches Generic Version of Caduet® TabletsView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on December 1, 2011 at 5:29 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan Launches Generic Version of Caduet® Tablets - http://t.co/LEjIBt2Y

6 months ago...

Mylan Inc. - Mylan Launches First Generic Version of Entocort EC® Capsules

investor.mylan.com — “Mylan Inc. - Mylan Launches First Generic Version of Entocort EC® CapsulesView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on June 24, 2011 at 11:00 am By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan Launches First Generic Version of Entocort EC® Capsules for #Crohn's - http://ow.ly/5pq2u

11 months ago...

Mylan Inc. - Mylan Introduces Educational Website About Generic Drugs, www.ChoosingGenerics.com

investor.mylan.com — “Mylan Inc. - Mylan Introduces Educational Website About Generic Drugs, www.ChoosingGenerics.comView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on March 23, 2011 at 3:20 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan Introduces Educational Website About Generic Drugs - http://ow.ly/4kMbA

1 year ago...

Mylan Inc. - Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg

investor.mylan.com — “Mylan Inc. - Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mgView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on March 10, 2011 at 3:42 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg - http://ow.ly/4bIzA

1 year ago...

Mylan Inc. - Mylan Launches First Generic Version of Vfend® Tablets

investor.mylan.com — “Mylan Inc. - Mylan Launches First Generic Version of Vfend® TabletsView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on February 15, 2011 at 3:31 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan Launches First Generic Version of Vfend® Tablets http://ow.ly/3WNgZ

1 year ago...

Mylan Inc. - Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets

investor.mylan.com — “Mylan Inc. - Mylan Receives Approval for First-to-File Generic Sular® Extended-Release TabletsView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on January 28, 2011 at 4:28 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets for treatment of hypertension - http://ow.ly/3M2KN

1 year ago...

Mylan Inc. - Mylan Launches Generic Version of Wellbutrin XL(R) Tablets

investor.mylan.com — “Mylan Inc. - Mylan Launches Generic Version of Wellbutrin XL(R) TabletsView full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on October 1, 2010 at 1:08 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Mylan Launches Generic Version of Wellbutrin XL(R) Tablets http://ow.ly/2MT1h

2 years ago...

Mylan Inc. - Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)

investor.mylan.com — “Mylan Inc. - Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)View full resource at investor.mylan.com

  • View Related
  • Share

Most Recently Shared on February 5, 2010 at 12:13 pm By:

FiercePharma FiercePharma Health Site

Mylan Confirms First-to-File Patent Challenge Relating to Caduet. http://bit.ly/aQxHKg

2 years ago...